Virtual Library
Start Your Search
M. Ayala León
Author of
-
+
P1.01 - Poster Session with Presenters Present (ID 453)
- Event: WCLC 2016
- Type: Poster Presenters Present
- Track: Epidemiology/Tobacco Control and Cessation/Prevention
- Presentations: 1
- Moderators:
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.01-034 - ECOG Scale of Performance Status in Lung Cancer at the First Consultation at a National Cancer Institute in a Developing Country in Latin America (ID 4548)
14:30 - 15:45 | Author(s): M. Ayala León
- Abstract
Background:
This article reviews ECOG scale values at the first consultation in our Institute, we review demographic and other related variables. ECOG at first consultation is related to treatment options.
Methods:
Between January 2004 and December 2013, all patients diagnosed with a pathology of SCLC and NSCLC at National Institute of Oncology at Paraguay were analyzed retrospectively. ECOG performance status, were recorded. SPSS 20 was used to analyze.
Results:
We studied 478 subjects. At age mean 60,40 [95% CI 59,45 to 61,34] years and ECOG performance status mean 2,13 [95% CI 2,06 to 2,20] points. Frequency of ECOG was to 2: 48.1%, to 3:31.3%, to 1: 19 %, to 4:1.1%, to 0: 0,6% of our population. Place of living predominant ECOG at Rural place: ECOG 2: 50%, ECOG 3: 30.6%. At Urban places ECOG 2:44.9% and ECOG 3:32.4% (P>0.05) ECOG and occupational relation was unemployed ECOG 2: 54.2%, Other professions ECOG 2: 46.9% , Farmers ECOG 2: 43.3,6% , homemakers ECOG 3: 50% (P= 0.008). Most of patient were smokers ECOG 4: 100%, ECOG 2: 86%, ECOG 3: 81%, ECOG 1: 76,1%, (P=0,000). Clinical severity and ECOG relation was predominant at ECOG 0 to Stage IIIB:66.7% and ECOG 1 to Stage IIIB:43.5%. And predominant at ECOG 2 was Stage IV: 54.7%, ECOG 3 and 4 was Stage IV: 60%, both (P=0,000). ECOG 1: 33,8% accept to chemotherapy ,ECOG 2: 46.6% Reject any treatment, ECOG 3: 43.9% Reject any treatment, ECOG 4: 40% accept to radiotherapy (P=0,000). Non-Small cell carcinoma predominant ECOG 2: 48.2% Small cell carcinoma: predominant ECOG 2: 48.1%(P>0.05).
Conclusion:
Our mean ECOG was 2.13 but predominance in our populations is ECOG 2 with 48% and ECOG 3 with 31%. Prevalence of ECOG 2 and 3 at first consultation was found at Rural and Urban Places. Statistical significance was found at work and ECOG performance with prevalence to ECOG 2 except to homemakers who had prevalence to ECOG 3. Association with smoking prevalence was ECOG 4 at first consultation. Is important to conclude that at ECOG 0 and 1 clinical stage IIIB was predominant and to ECOG 2 to 4 was clinical stage IV, which shows relation between clinical severity and ECOG performance, but multivariate analysis will be required. Relation between treatment show a high rejection to treatment at ECOG 2 and 3. With this analysis we need to seek a logistic regression model to search relation with ECOG performance and other variables.
